This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Nerviano Medical Sciences S.r.l.. Active years: 2013-2014.
Company Filing History:
Years Active: 2013-2014
Title: Annalisa Airoldi: Innovator in Pharmaceutical Sciences
Introduction
Annalisa Airoldi is a prominent inventor based in Nosate, Italy. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of novel crystalline forms of inhibitors that have therapeutic applications. With a total of two patents to her name, Airoldi's work is paving the way for advancements in medical treatments.
Latest Patents
Annalisa Airoldi's latest patents include innovative formulations of PLK inhibitor salts and CDK inhibitor salts. The PLK inhibitor salts patent describes novel crystalline, water-soluble salts, including L-tartrate, succinate, phosphate, and several others. These salts are essential for their utility in therapy and the pharmaceutical compositions that contain them. The CDK inhibitor salts patent focuses on new crystalline forms of water-soluble salts and free bases of a CDK inhibitor, including fumarate, L-malate, and hydrochloride, among others. Both patents detail the preparation processes, utility in therapy, and the pharmaceutical compositions that utilize these new salt forms.
Career Highlights
Annalisa Airoldi is currently associated with Nerviano Medical Sciences S.r.l., where she continues to innovate in the pharmaceutical sector. Her work is characterized by a commitment to enhancing therapeutic options through the development of new chemical entities.
Collaborations
Annalisa collaborates with esteemed colleagues such as Massimo Zampieri and Italo Beria, contributing to a dynamic research environment that fosters innovation and scientific discovery.
Conclusion
Annalisa Airoldi's contributions to pharmaceutical sciences through her patents and collaborations highlight her role as a key innovator in the field. Her work not only advances medical treatments but also exemplifies the importance of research and development in improving healthcare outcomes.